The templated letter sent across industry reiterates many of the same concerns highlighted in the press release and serves as notice of FDA’s enforcement approach to all drug application holders, ...
The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. President Trump and HHS Secretary Kennedy emphasize transparency and ...
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks. By Rebecca Robbins Christina Jewett and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback